When GMP Compliance Becomes Commercial Deal Risk
Why pharmaceutical supply, FDA inspections and manufacturing compliance belong in the commercial contract, not just the Quality Agreement A pharmaceutical company can have an approved ANDA, a favorable patent position, launch inventory plans and customers waiting, and still miss the market because its API supplier cannot release compliant material. The same manufacturing problem can derail […]